Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations (2026)
Chapter: Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix C: Public Meeting Agendas
Appendix D
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
Appendix D
Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research
This appendix provides a non-exhaustive set of supplemental questions intended to support institutional committees, funders, and policy makers in evaluating biosafety, biosecurity, environmental, chemical safety, and cross-cutting governance considerations for synthetic cell research. These questions are designed to complement, rather than replace, existing biosafety, dual use research of concern, and regulatory review frameworks. They are not intended as a checklist or prescriptive requirements, but rather as decision-support prompts to help identify when additional scrutiny, coordination, or expertise may be warranted, particularly for research that does not fit neatly within traditional oversight categories.
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
| Question | Primary Domain(s) | Why This Question Matters for Evaluation |
|---|---|---|
| Does the research meaningfully lower technical barriers to constructing, scaling, or deploying biologically active systems, even if the current construct itself is low risk? | Biosecurity; dual use | A “yes” may indicate increased downstream misuse potential even when near-term risks are limited. |
| Does the work combine multiple enabling capabilities (e.g., design automation, synthesis, delivery, scale, or autonomy) in ways that could increase misuse potential when taken together? | Biosecurity; cross-cutting | Converging capabilities may elevate concern even if individual elements appear benign. |
| Could the system, its components, or its outputs be difficult to detect, monitor, or attribute using existing laboratory, environmental, or forensic tools? | Biosecurity; environmental monitoring | Limited detectability may affect surveillance, incident response, or accountability. |
| Does the research rely on non-canonical chemistries, mirror-image components, or artificial polymers that challenge current oversight, monitoring, or compliance frameworks? | Biosecurity; chemical safety | Novel chemistries may fall outside established regulatory, safety, or monitoring assumptions. |
| Does the research introduce chemical hazards (e.g., toxic intermediates, reactive compounds, or novel materials) that may pose occupational, environmental, or waste-management risks independent of biological activity? | Chemical safety; environmental health | A “yes” may indicate the need for chemical safety review, industrial hygiene controls, or environmental health expertise beyond traditional biosafety oversight. |
| Is the work plausibly adaptable to settings beyond those originally intended, even if such adaptation is not the stated goal? | Biosecurity; governance | High adaptability may warrant earlier or broader review across use contexts. |
| Does the research involve pathogens, pathogenic components, or delivery vectors derived from pathogenic systems undertaken for legitimate scientific, medical, or industrial purposes? | Biosecurity; biosafety | Long-standing dual use considerations may apply even when work is clearly beneficial. |
| Would this work trigger biosecurity or dual use review under existing institutional or federal frameworks, and if not, is there a clear rationale for why additional review is unnecessary? | Governance; oversight | Identifies potential gaps where review may be inconsistent or absent. |
| Would earlier or more integrated biosecurity review reduce downstream risk without materially constraining legitimate research progress? | Governance; cross-cutting | Early review may offer low-cost risk reduction before development trajectories become fixed. |
| Could dissemination of methods, data, or materials associated with this research warrant additional consideration regarding responsible communication, access, or control? | Biosecurity; governance | Some outputs may merit tailored dissemination practices to reduce misuse risk. |
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
| Question | Primary Domain(s) | Why This Question Matters for Evaluation |
|---|---|---|
| Could release, intentional or accidental, lead to environmental effects (e.g., persistence, accumulation, or interaction with ecosystems) even in the absence of replication or pathogenicity? | Environmental; ecological oversight | Environmental impacts may arise from functional activity or material properties rather than from living status alone. |
| Is it clear whether biosafety, chemical safety, or environmental health and safety oversight should take primary responsibility for review, or does the work fall between existing oversight domains? | Chemical safety; governance | Ambiguity about oversight jurisdiction can lead to gaps, duplication, or inconsistent risk management. |
| Does the work raise coordination challenges across biosafety, biosecurity, chemical safety, and environmental oversight domains that are not well addressed by single-domain review processes? | Cross-cutting; governance | Integrated oversight may be more appropriate than siloed review for hybrid or novel systems. |
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
This page intentionally left blank.
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
Suggested Citation:
"Appendix D: Biosecurity, Dual Use, and Cross-Domain Oversight Questions for Synthetic Cell Research." National Academies of Sciences, Engineering, and Medicine. 2026. Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations. Washington, DC: The National Academies Press.
doi: 10.17226/29325.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.